Singlife Multipay Critical Illness II: What’s New & Better?

When considering plans like the new Singlife Multipay Critical Illness II, let’s talk about something that’s on many of our minds here in Singapore: critical illness (CI). We all know someone—a family member, a friend, or a colleague—whose life has been turned upside down by a serious diagnosis. With healthcare costs on the rise, having a financial safety net isn’t just a ‘nice-to-have’; it’s a cornerstone of sound financial planning.

Historically, a standard CI plan was simple: you get diagnosed, you get a one-time payout, and the policy ends. However, medical advancements mean that more people are surviving and living longer after a diagnosis. Consequently, this raises a new concern: what happens if the illness comes back, or if a completely different one strikes later?

This is where multi-pay critical illness plans come in, and insurers are constantly updating their offerings. One of the latest on the market is the Singlife Multipay Critical Illness II. But is it just a repackaged version of its predecessor (Singlife Multipay Critical Illness), or is it genuinely new and better? Let’s break it down in simple terms.

Understanding The Core Features Of Singlife Multipay Critical Illness II

At its heart, the Singlife Multipay Critical Illness II is designed for our modern reality, where surviving a critical illness is increasingly common, but so is the risk of recurrence. It’s built to provide financial support not just once, but potentially multiple times throughout your life.

Here’s a quick look at the headline features:

1. Broad Coverage: The plan covers 135 different medical conditions, spanning early, intermediate, and severe stages.
2. High Payout Potential: The plan allows for multiple claims, with a total potential payout of up to 900% of the Sum Assured. In simple terms, the “Sum Assured” is the amount of coverage you buy. So, a $100,000 plan has the potential to pay out up to $900,000 over its lifetime.
3. Premium Waiver: If you are diagnosed with your first severe-stage critical illness, you stop paying all future premiums, but your remaining coverage continues. This is a huge relief, as it means you can focus on recovery without worrying about policy payments.

1) From ‘Pots’ to a Linear System: A Key Update in Singlife Multipay Critical Illness II

One of the most significant changes in the Singlife Multipay Critical Illness II is how it handles claims for early-stage illnesses. To understand why this is a big deal, we need to look at the old system.

Previously, plans like these used a “pot” system. Imagine having three separate buckets of money: one for cancer-related illnesses, one for heart-related conditions, and one for neurological issues. You could claim once from each bucket. The good thing was, you could make claims from different buckets in quick succession with no waiting period. The downside? Once you claimed from the “heart” bucket, you couldn’t make another early-stage claim for any other heart-related issue from that same bucket again.

The new Singlife Multipay Critical Illness II completely moves away from this rigid pot system. Now, it uses a more flexible, linear structure. This means you can make multiple early-stage claims for any covered condition, regardless of its medical category.

2) The Important Trade-Off in Singlife Multipay Critical Illness II: The One-Year Waiting Period

This newfound flexibility sounds great, but it comes with a very important trade-off. To manage the risk of too many claims in a short period, the Singlife Multipay Critical Illness II introduces mandatory waiting periods between claims. This is one year between two early or intermediate stage claims, one year between two severe stage claims, and a two-year period from the last CI Benefit claim before a recurrent illness claim can be made.

Let’s use an example. Under the old “pot” system, you could have been diagnosed with early-stage cancer (Pot 1) in January and an unrelated early-stage heart condition (Pot 2) in March, receiving two full payouts quickly.

Under the new Singlife Multipay Critical Illness II, however, the second claim for the heart condition would only be paid if the diagnosis happened at least one year after the cancer diagnosis in January. This change means the plan is less ideal for the unlucky scenario of getting two separate early-stage illnesses in a short time. In contrast, it’s arguably better for a long-term health journey where illnesses might appear years apart.

3) The Market-Leading Recurrence Benefit

Now, let’s talk about the standout feature and the plan’s biggest selling point: its powerful protection against recurring illnesses. Medical data highlights the significant risk of recurrence for certain conditions; for instance, some studies indicate four in ten stroke patients may have another stroke within a decade. The Singlife Multipay Critical Illness II is built specifically to address this fear.

If you suffer a relapse of one of six specified major conditions, the plan pays out a massive 150% of your Sum Assured for each recurrence claim, up to two times. This is one of the highest recurrent payouts on the market.

This powerful benefit focuses on six conditions known for high relapse rates:

1. Major Cancer
2. Heart Attack of Specified Severity
3. Stroke with Permanent Neurological Deficit
4. Open Chest Heart Valve Surgery
5. Major Organ/Bone Marrow Transplantation
6. Coronary Artery By-pass Surgery

For someone with a family history of these conditions, this feature alone makes the plan incredibly compelling.

4) The Advance Care Option: A Critical Financial Decision at a Vulnerable Time

Paired with the powerful recurrence benefit is another unique feature called the Advance Care Option. However, it presents you with a difficult choice at a very vulnerable time.

Here’s how it works: upon your first severe-stage diagnosis of one of those same six conditions, you have a choice to make:

1. Option A: Do nothing and keep your Recurrent Illness Benefit (the 2x 150% payouts) for potential future relapses.
2. Option B: Exercise the Advance Care Option. This gives you an immediate extra cash payout of 75% of your Sum Assured, on top of your severe-stage payout.

The catch? If you choose Option B, you permanently give up your entire Recurrent Illness Benefit.

Imagine you have a $100,000 policy. Taking the Advance Care Option means getting an extra $75,000 in cash right away. This could be a lifesaver for funding treatments or managing finances. However, you would be forfeiting the potential for two future payouts of $200,000 each. It’s a classic trade-off: more cash now versus more protection for the future.

Exploring the Ancillary Benefits of Singlife Multipay Critical Illness II

Beyond the major payouts, the Singlife Multipay Critical Illness II also includes several smaller, supplementary benefits. These cover serious health events that might not qualify as a full-blown critical illness, adding another layer of financial support.

1. Intensive Care (ICU) Benefit: If you need to stay in the ICU for four or more days due to an illness or accident, you get a one-time payout of 20% of your Sum Assured (capped at S$25,000).
2. Benign and Borderline Malignant Tumour Benefit: This provides a one-time payout of 20% of your Sum Assured (capped at S$25,000) for the surgical removal of a benign tumour (where cancer is suspected) or for a borderline malignant tumour diagnosis.
3. Special Benefit: This covers 34 specified conditions. You can receive 20% of your Sum Assured (capped at S$25,000 per condition) for up to six different conditions.

These smaller benefits make the plan more comprehensive, increasing the chances that you’ll receive some financial help when you need it most.

A Competitive Look at the Singlife Multipay Critical Illness II

So, how does this plan compare to others in the market? The Singlife Multipay Critical Illness II positions itself as a specialist plan.

Its main strength is undoubtedly the huge 150% payout for recurrent illnesses, making it a top contender for anyone worried about relapse. In terms of cost, it is also competitively priced against its peers, especially with ongoing promotions.

However, its key weakness is the one-year waiting period between early-stage claims. Another competitive plan, like the Tokio Marine’s TM MultiCare, for example, may not have a waiting period for claims from different illness categories, making it potentially faster for unrelated diagnoses. But this advantage might come at a significantly higher premium.

Final Thoughts On The Singlife Multipay Critical Illness II

So, is the Singlife Multipay Critical Illness II new and better?

It is definitely new. The shift away from the “pot” system, the introduction of the Advance Care Option, and the market-leading 150% recurrence payout are fundamental changes, not just minor tweaks.

Whether it is better depends entirely on you.

• It is better if your primary concern is getting the maximum possible financial firepower to fight a recurrence of major illnesses like cancer, heart attack, or stroke.
• It may be less suitable if you’re more concerned about the possibility of being diagnosed with multiple, unrelated early-stage conditions within a single year.

Ultimately, the Singlife Multipay Critical Illness II is a powerful and highly specialized tool designed for the modern healthcare landscape. It acknowledges that the fight against a critical illness doesn’t always end after the first diagnosis. Making the right choice requires understanding if its unique structure aligns with your protection strategy.

If you’d like to explore this further, our team is here to help with a 100% free, no-obligation consultation designed purely to provide you with clarity.

Complete the contact form below to start a conversation with us today.